Androgens raise red blood cell production. A high haematocrit rarely causes symptoms early, which is why it is easy to miss.
What changes
Testosterone and related androgens stimulate red blood cell production. In testosterone therapy trials, raised haematocrit is one of the most common adverse findings.
Higher red cell mass makes blood more viscous, which is a plausible contributor to clot and cardiovascular risk.
Why symptoms are unreliable
Headache, flushing or fatigue are non-specific. Many people with elevated values feel nothing at all.
A full blood count is the only practical way to know where values sit.
What to do
Discuss results with a clinician who knows every substance being taken. Dehydration can also distort results, so context matters.
Do not self-manage with home blood removal; it carries infection and iron-deficiency risks.
In short
- Raised haematocrit is common with androgen exposure.
- It is usually silent; only blood tests reveal it.
- Clinical management, not self-treatment, is appropriate.
Cited studies
These studies provide context for the article; findings may not apply to non-medical use or products sold online.
Ohlander SJ, Varghese B, Pastuszak AW. (2018). Erythrocytosis following testosterone therapy. Sexual Medicine Reviews.
Read the study ↗Bhasin S, Brito JP, Cunningham GR, et al. (2018). Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism.
Read the study ↗
Unfamiliar terminology is defined in our glossary. How we research and grade evidence is set out in our editorial standards, and errors can be reported through corrections.
This article is educational. It is not medical advice, a dosing recommendation, or an endorsement of use. Speak with a qualified medical practitioner about your circumstances.